Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Orbach

Showing results (271-280 of 351) with videos related to

Pageof 36
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 6, 2016
Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experienceDaniel Orbach, Bernadette Brennan, Angela De Paoli, et al.
Cancer|May 26, 2018
Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)Soledad Gallego, Ilaria Zanetti, Daniel Orbach, et al.
Cancer|February 24, 2024
Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogramGian Luca De Salvo, Paola Del Bianco, Veronique Minard-Colin, et al.
Critical Reviews in Oncology/Hematology|June 3, 2026
Translational aspects of Desmoplastic Small Round Cell Tumor (DSRCT): An expert consensus paper from the OCTOPUS groupSandro Pasquali, Valentina Doldi, Janet M Shipley, et al.
The Lancet. Oncology|September 29, 2019
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trialGianni Bisogno, Gian Luca De Salvo, Christophe Bergeron, et al.
Bulletin Du Cancer|April 16, 2022
NUT carcinoma in children, adolescents and young adultsLauriane Lemelle, Antoine Moya-Plana, Benoît Dumont, et al.
Pediatric Blood & Cancer|July 14, 2020
Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experienceMorgane Pondrom, Gaelle Bougeard, Marie Karanian, et al.
Journal of Pediatric Hematology/Oncology|February 7, 2007
Multicenter randomized trial of chewing gum for preventing oral mucositis in children receiving chemotherapyVirginie Gandemer, Marie-Cécile Le Deley, Catherine Dollfus, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2025
NUT carcinoma in children and adolescents: An analysis of the European Cooperative Study Group on pediatric rare tumors (EXPeRT)Tim Flaadt, Lauriane Lemelle, Michael Abele, et al.
Pediatric Blood & Cancer|September 26, 2022
The French FRACTURE database: A way to improve knowledge on management of children with very rare tumorsCoralie Mallebranche, Yves Reguerre, Brice Fresneau, et al.
Pageof 36

Showing results (271-280 of 351) with videos related to

Sort By:
Pageof 36
European Journal of Cancer (Oxford, England : 1990)|February 6, 2016
Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experienceDaniel Orbach, Bernadette Brennan, Angela De Paoli, et al.
Cancer|May 26, 2018
Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)Soledad Gallego, Ilaria Zanetti, Daniel Orbach, et al.
Cancer|February 24, 2024
Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogramGian Luca De Salvo, Paola Del Bianco, Veronique Minard-Colin, et al.
Critical Reviews in Oncology/Hematology|June 3, 2026
Translational aspects of Desmoplastic Small Round Cell Tumor (DSRCT): An expert consensus paper from the OCTOPUS groupSandro Pasquali, Valentina Doldi, Janet M Shipley, et al.
The Lancet. Oncology|September 29, 2019
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trialGianni Bisogno, Gian Luca De Salvo, Christophe Bergeron, et al.
Bulletin Du Cancer|April 16, 2022
NUT carcinoma in children, adolescents and young adultsLauriane Lemelle, Antoine Moya-Plana, Benoît Dumont, et al.
Pediatric Blood & Cancer|July 14, 2020
Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experienceMorgane Pondrom, Gaelle Bougeard, Marie Karanian, et al.
Journal of Pediatric Hematology/Oncology|February 7, 2007
Multicenter randomized trial of chewing gum for preventing oral mucositis in children receiving chemotherapyVirginie Gandemer, Marie-Cécile Le Deley, Catherine Dollfus, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2025
NUT carcinoma in children and adolescents: An analysis of the European Cooperative Study Group on pediatric rare tumors (EXPeRT)Tim Flaadt, Lauriane Lemelle, Michael Abele, et al.
Pediatric Blood & Cancer|September 26, 2022
The French FRACTURE database: A way to improve knowledge on management of children with very rare tumorsCoralie Mallebranche, Yves Reguerre, Brice Fresneau, et al.
Pageof 36